Daniel O’Reilly

477 total citations
17 papers, 229 citations indexed

About

Daniel O’Reilly is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel O’Reilly has authored 17 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel O’Reilly's work include CRISPR and Genetic Engineering (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Daniel O’Reilly is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), RNA Interference and Gene Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Daniel O’Reilly collaborates with scholars based in United States, Canada and Netherlands. Daniel O’Reilly's co-authors include Masad J. Damha, Keith T. Gagnon, Tomislav Friščić, Frank Rigo, Jonathan K. Watts, Vivek Sharma, Xiulong Shen, Thazha P. Prakash, David R. Corey and Annemieke Aartsma‐Rus and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Reviews Drug Discovery.

In The Last Decade

Daniel O’Reilly

16 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel O’Reilly United States 9 198 38 25 19 12 17 229
Soumyashree A. Gangopadhyay United States 7 304 1.5× 12 0.3× 23 0.9× 34 1.8× 7 0.6× 8 340
Birong Cao China 4 239 1.2× 14 0.4× 34 1.4× 17 0.9× 30 2.5× 5 265
Apekshya Panda United States 4 217 1.1× 25 0.7× 12 0.5× 11 0.6× 4 0.3× 4 238
Benedikt S. Nilges Germany 11 444 2.2× 12 0.3× 24 1.0× 3 0.2× 8 0.7× 13 484
Cole Urnes United States 3 291 1.5× 9 0.2× 68 2.7× 18 0.9× 5 0.4× 3 328
Kaiwen Ivy Liu Singapore 4 213 1.1× 7 0.2× 35 1.4× 20 1.1× 4 0.3× 6 227
Jia Hui Jane Lee Singapore 4 193 1.0× 8 0.2× 22 0.9× 20 1.1× 2 0.2× 5 227
Manav Gupta United States 2 125 0.6× 28 0.7× 22 0.9× 7 0.4× 3 0.3× 5 132
Martin J. Kurian United States 7 302 1.5× 27 0.7× 14 0.6× 14 1.2× 14 392
Keewon Sung South Korea 6 299 1.5× 4 0.1× 34 1.4× 36 1.9× 11 0.9× 10 320

Countries citing papers authored by Daniel O’Reilly

Since Specialization
Citations

This map shows the geographic impact of Daniel O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel O’Reilly more than expected).

Fields of papers citing papers by Daniel O’Reilly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel O’Reilly. The network helps show where Daniel O’Reilly may publish in the future.

Co-authorship network of co-authors of Daniel O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel O’Reilly. A scholar is included among the top collaborators of Daniel O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel O’Reilly. Daniel O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
O’Reilly, Daniel, et al.. (2025). Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs. Nucleic Acid Therapeutics. 35(3). 137–149. 1 indexed citations
2.
Sapp, Ellen, Jillian Belgrad, Rachael Miller, et al.. (2025). Mutant huntingtin exon 1 protein detected in mouse brain with neoepitope antibody: effects of CAG repeat expansion, MutS Homolog 3 silencing and aggregation. Brain Communications. 7(5). fcaf314–fcaf314. 1 indexed citations
3.
O’Reilly, Daniel, et al.. (2024). A Guide to Chemical Considerations for the Pre-Clinical Development of Oligonucleotides. Nucleic Acid Therapeutics. 34(6). 295–298. 2 indexed citations
4.
Echeverria, Dimas, et al.. (2024). Near Sequence Homology Does Not Guarantee siRNA Cross-Species Efficacy. Nucleic Acid Therapeutics. 34(5). 234–244. 1 indexed citations
5.
Allen, Sarah E., Daniel O’Reilly, Rachael Miller, et al.. (2024). mRNA Nuclear Clustering Leads to a Difference in Mutant Huntingtin mRNA and Protein Silencing by siRNAs In Vivo. Nucleic Acid Therapeutics. 34(4). 164–172. 1 indexed citations
6.
Gagnon, Keith T., et al.. (2024). Chemical engineering of CRISPR–Cas systems for therapeutic application. Nature Reviews Drug Discovery. 24(3). 209–230. 10 indexed citations
7.
O’Reilly, Daniel, David van de Vijver, Ingrid E.C. Verhaart, et al.. (2023). Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 33(6). 348–360. 7 indexed citations
8.
Aartsma‐Rus, Annemieke, Elizabeth Vroom, & Daniel O’Reilly. (2021). The Role of Patient Involvement When Developing Therapies. Nucleic Acid Therapeutics. 32(2). 118–122. 7 indexed citations
9.
O’Reilly, Daniel, et al.. (2021). Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles. Nature Communications. 12(1). 6591–6591. 20 indexed citations
10.
O’Reilly, Daniel, et al.. (2021). Small nucleic acids and the path to the clinic for anti-CRISPR. Biochemical Pharmacology. 189. 114492–114492. 4 indexed citations
11.
O’Reilly, Daniel, et al.. (2020). Mechanochemical Synthesis of Short DNA Fragments. Chemistry - A European Journal. 26(41). 8857–8861. 22 indexed citations
12.
O’Reilly, Daniel, et al.. (2019). Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9. Nucleic Acid Therapeutics. 29(3). 136–147. 28 indexed citations
13.
Shen, Xiulong, Audrius Kilikevičius, Daniel O’Reilly, et al.. (2018). Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion. Bioorganic & Medicinal Chemistry Letters. 28(17). 2850–2855. 17 indexed citations
14.
Debacker, Alexandre J., et al.. (2018). Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing. Biochemistry. 58(6). 582–589. 9 indexed citations
15.
O’Reilly, Daniel, et al.. (2018). Exploring Atypical Fluorine–Hydrogen Bonds and Their Effects on Nucleoside Conformations. Chemistry - A European Journal. 24(61). 16432–16439. 14 indexed citations
16.
Li, Liande, Xiulong Shen, Zhongtian Liu, et al.. (2018). Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat. Nucleic Acid Therapeutics. 28(1). 23–33. 33 indexed citations
17.
O’Reilly, Daniel, et al.. (2018). Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity. Nucleic Acids Research. 47(2). 546–558. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soumyashree A. Gangopadhyay Breakdown of academic impact, for papers by Birong Cao Breakdown of academic impact, for papers by Apekshya Panda Breakdown of academic impact, for papers by Benedikt S. Nilges Breakdown of academic impact, for papers by Cole Urnes Breakdown of academic impact, for papers by Kaiwen Ivy Liu Breakdown of academic impact, for papers by Jia Hui Jane Lee Breakdown of academic impact, for papers by Manav Gupta Breakdown of academic impact, for papers by Martin J. Kurian Breakdown of academic impact, for papers by Keewon Sung
Rankless by CCL
2026